Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis

BACKGROUND: Severe malaria is a leading cause of morbidity and mortality in under-fives in sub-Saharan Africa. Recently quinine has been replaced by artesunate as the first-line drug in the treatment of severe malaria in Cameroon. Artesunate has been shown to be cost-effective in African children, b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Malar J
Autors principals: Maka, Daniel Ethe, Chiabi, Andreas, Obadeyi, Bolaji, Mah, Evelyn, Nguefack, Séraphin, Nana, Pamela, Mbacham, Wilfred, Mbonda, Elie
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5142138/
https://ncbi.nlm.nih.gov/pubmed/27923381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-016-1639-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars